Therefore, acetylcholinesterase inhibitors are conventionally recognized as first-line drugs in AD treatment, mainly comprising rivastigmine, galantamine and donepezil, which are commonly employed in mild AD cases [11]. The gene discussed is ACHE; the disease is Alzheimer disease.